Mupirocin

Suppliers

Names

[ CAS No. ]:
12650-69-0

[ Name ]:
Mupirocin

[Synonym ]:
Pseudomonic acid
9-({(2E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxy-2-butanyl]-2-oxiranyl}methyl)tetrahydro-2H-pyran-2-yl]-3-methyl-2-butenoyl}oxy)nonanoic acid
9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid (non-preferred name)
Bactoderm
MFCD03792664
Pseudomonic acid A
Mupirocin
EINECS 231-791-2
Turixin
BACTROBAN
Mupirocin [USAN:BAN:INN]
Mupirocina
trans-Pseudomonic Acid
Bactroban Nasal
Plasimine
9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid
9-({(2E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid (non-preferred name)
Mupirocine
Mupirocinum
[2S-[2a(E),3b,4b,5a[2R*,3R*(1R*,2R*)]]]-9-[[3-Methyl-1-oxo-4-[tetrahydro-3,4-dihydroxy-5-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-2H-pyran-2-yl]-2-butenyl]oxy]nonanoic Acid
Centany
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
672.3±55.0 °C at 760 mmHg

[ Melting Point ]:
77-780C

[ Molecular Formula ]:
C26H44O9

[ Molecular Weight ]:
500.622

[ Flash Point ]:
216.5±25.0 °C

[ Exact Mass ]:
500.298523

[ PSA ]:
146.05000

[ LogP ]:
3.44

[ Vapour Pressure ]:
0.0±4.7 mmHg at 25°C

[ Index of Refraction ]:
1.524

[ Storage condition ]:
-20°C Freezer, Under Inert Atmosphere

[ Water Solubility ]:
H2O: 12 mg/mL, soluble

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ Safety Phrases ]:
S2

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
2

[ RTECS ]:
RA6907000

[ HS Code ]:
2941909000

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • D-Ribose
  • 1,5-Anhydro-D-arabinitol
  • (3S,4R)-3-METHYL-4-N-PHENYLAMINO-PIPERIDINE
  • 3-[2-(TERT-BUTYL-DIPHENYL-SILANYLOXY)-ETHYL]-3,4-DIHYDRO-2H-PYRAN-4-OL
  • 2-((2S,5R)-5-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-5,6-dihydro-2H-pyran-2-yl)-N,N-dimethylacetamide
  • ethyl (E)-4-((3a'S,4'S,7'S,7a'R)-7'-(2-((tert-butyldiphenylsilyl)oxy)ethyl)tetrahydro-4'H-spiro[cyclohexane-1,2'-[1,3]dioxolo[4,5-c]pyran]-4'-yl)-3-methylbut-2-enoate
  • METHYL4-NITROBENZENESULFONATE
  • 5S-IODO-1S,6S-3,7-DIOXABICYCLO[4,3,0]-NONAN-8-ONE
  • 2-(R)-3,6-DIHYDRO-2H-PYRAN-3-YL-N,N-DIMETHYL-ACETAMIDE
  • (E)-5,9-anhydro-6,7-O-cyclohexylidene-2,3,4,8-tetradeoxy-8-C-(ethoxycarbonyl)methyl-3-methyl-D-allo-non-2-enitol

DownStream

Customs

[ HS Code ]: 2941909000

Articles

Purification and characterization of the Staphylococcus aureus bacillithiol transferase BstA.

Biochim. Biophys. Acta 1840(9) , 2851-61, (2014)

Gram-positive bacteria in the phylum Firmicutes synthesize the low molecular weight thiol bacillithiol rather than glutathione or mycothiol. The bacillithiol transferase YfiT from Bacillus subtilis wa...

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

J. Sci. Ind. Res. 65(10) , 808, (2006)

Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ...

Simultaneous monitoring of Staphylococcus aureus growth in a multi-parametric microfluidic platform using microscopy and impedance spectroscopy.

Bioelectrochemistry 105 , 56-64, (2015)

We describe the design, construction, and characterization of a scalable microfluidic platform that allows continuous monitoring of biofilm proliferation under shear stress conditions. Compared to oth...


More Articles

Related Compounds

  • Mupirocin
  • MupirocinCalcium
  • Mupirocin calcium
  • Dihydro Mupirocin
  • Lithium mupirocin
  • Mupirocin EP Impurity D
  • N1-[[2-[5-(1H-pyrazol-4-yl)-1H-indazol-3-yl]-1H-indol-5-yl]methyl]-1,4-cyclohexane diamine
  • N-2-pyridinyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-carboxamide
  • N-3-isoxazolyl-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
  • N-hydroxy-1-isopropyl-1H-indazole-7-carboximidamide
  • N-hydroxy-1-methyl-1H-indazole-4-carboximidamide
  • N-hydroxy-2-isopropyl-2H-indazole-7-carboximidamide
  • N-hydroxy-2-isopropylbenzo[d]oxazole-4-carboximidamide
  • 2-(1-((2-Chloropyrimidin-5-yl)methyl)piperidin-3-yl)-6-(thiophen-2-yl)pyrimidin-4(3h)-one
  • 2-(1H-1,2,4-triazol-1-yl)-3-thiophenamine
  • N-methyl-3-[3-[3-[(methylamino)carbonyl]phenyl]imidazo[1,2-b]pyridazin-7-yl]benzamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.